SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-19-002640
Filing Date
2019-04-25
Accepted
2019-04-25 16:05:16
Documents
13
Period of Report
2019-06-18
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042519.htm DEF 14A 1109046
2 GRAPHIC logo.jpg GRAPHIC 33624
3 GRAPHIC cheungsig.jpg GRAPHIC 2372
4 GRAPHIC graph.jpg GRAPHIC 42637
5 GRAPHIC blanchard.jpg GRAPHIC 5584
6 GRAPHIC bower.jpg GRAPHIC 5540
7 GRAPHIC darling.jpg GRAPHIC 5500
8 GRAPHIC land.jpg GRAPHIC 5613
9 GRAPHIC larsen.jpg GRAPHIC 4961
10 GRAPHIC thompson.jpg GRAPHIC 32972
11 GRAPHIC vogt.jpg GRAPHIC 5753
12 GRAPHIC proxycard_1.jpg GRAPHIC 176622
13 GRAPHIC proxycard_2.jpg GRAPHIC 134401
  Complete submission text file 0001171843-19-002640.txt   1738808
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 19767429
SIC: 3841 Surgical & Medical Instruments & Apparatus